<?xml version="1.0" encoding="UTF-8"?>
<p>It was invented 40 years ago by a joint consortium of Russian scientists arbidol has been employed in China since 2006 for the treatment and prophylaxis of human pulmonary diseases caused by influenza A and B viruses and of other human pathogenic respiratory viruses and it has been present in the Russian market for 20 years [
 <xref rid="B71-medicina-56-00386" ref-type="bibr">71</xref>]. It has also proven useful for the prevention of the epidemic of poultry flu in China. Its clinical efficacy was first reported and published in Russia in the 1990s [
 <xref rid="B71-medicina-56-00386" ref-type="bibr">71</xref>,
 <xref rid="B72-medicina-56-00386" ref-type="bibr">72</xref>]. It is cost-effective in prophylactic and curative treatments, against acute respiratory viral infections [
 <xref rid="B72-medicina-56-00386" ref-type="bibr">72</xref>].
</p>
